Loss of circadian clock gene expression is associated with tumor progression in breast cancer. - Wikidata - wikimedia - TriplyDB

Loss of circadian clock gene expression is associated with tumor progression in breast cancer.

Loss of circadian clock gene expression is associated with tumor progression in breast cancer.

http://www.wikidata.org/entity/Q36185967

about

Transcriptional pathways altered in response to vibration in a model of hand-arm vibration syndrome Lipid-sensors, enigmatic-orphan and orphan nuclear receptors as therapeutic targets in breast-cancer Evolving roles of circadian rhythms in liver homeostasis and pathology The circadian clock modulates anti-cancer properties of curcumin.MYC/MIZ1-dependent gene repression inversely coordinates the circadian clock with cell cycle and proliferation.Circadian clocks and breast cancer Cellular mechano-environment regulates the mammary circadian clock Estradiol differently affects melanin synthesis of malignant and normal melanocytes: a relationship with clock and clock-controlled genes.The Circadian Rhythm Gene Arntl2 Is a Metastasis Susceptibility Gene for Estrogen Receptor-Negative Breast Cancer.Highlight report: Erroneous sample annotation in a high fraction of publicly available genome-wide expression datasets Retinoic Acid-Related Orphan Receptors (RORs): Regulatory Functions in Immunity, Development, Circadian Rhythm, and Metabolism.ERα Mediates Estrogen-Induced Expression of the Breast Cancer Metastasis Suppressor Gene BRMS1.The important tumor suppressor role of PER1 in regulating the cyclin-CDK-CKI network in SCC15 human oral squamous cell carcinoma cells Period2 downregulation inhibits glioma cell apoptosis by activating the MDM2-TP53 pathway.Differential Phasing between Circadian Clocks in the Brain and Peripheral Organs in Humans.Inhibition of expression of the circadian clock gene Period causes metabolic abnormalities including repression of glycometabolism in Bombyx mori cells.Genetics of Circadian Rhythms.Identification of circadian-related gene expression profiles in entrained breast cancer cell lines.SIRT1 and circadian gene expression in pancreatic ductal adenocarcinoma: Effect of starvation.Highlight report: Predicting late metastasis in breast cancer Highlight report: Limits of prognostication of non-small cell lung cancer.Highlight report: Role of the circadian clock system in breast cancer.Research progress on circadian clock genes in common abdominal malignant tumors.GDPD5, a choline-generating enzyme and its novel role in tumor cell migration.Highlight report: The EDI3-GPAM axis in tumor cell migration.Requisite role of vasohibin-2 in spontaneous gastric cancer formation and accumulation of cancer-associated fibroblasts.Prognostic significance of downregulated BMAL1 and upregulated Ki-67 proteins in nasopharyngeal carcinoma.Dosing time dependent in vitro pharmacodynamics of Everolimus despite a defective circadian clock.Vitamin D signaling and melanoma: role of vitamin D and its receptors in melanoma progression and management.Highlight report: Intratumoral metabolomic heterogeneity of breast cancer.Evidence for widespread dysregulation of circadian clock progression in human cancer.Intracellular lysophosphatidic acid influences cell migration.Circadian clock and oral cancer.Selective changes in cholesterol metabolite levels in plasma of breast cancer patients after tumor removal.Genome-wide Methyl-Seq analysis of blood-brain targets of glucocorticoid exposure.Altered Circadian Rhythms and Breast Cancer: From the Human to the Molecular Level Cryptochrome 2 (CRY2) Suppresses Proliferation and Migration and Regulates Clock Gene Network in Osteosarcoma Cells.Altered circadian genes expression in breast cancer tissue according to the clinical characteristics.

P2860

Q24853136-71BCED93-60A4-4E82-B0E1-6B34680E3281 Q26764743-816A8BA9-D402-46AB-AEA5-CB3A9037C5A2 Q27010130-A4715C38-C5D6-41DF-812E-CCFA6FEB9BC9 Q27311369-39091051-0CFB-4AA1-8659-4B63447F753F Q27314468-588D9276-81BA-4C61-BFDD-81FDCE999709 Q28077656-FB1E5299-5ED5-4DE9-8D2B-91DDCA1AC5A5 Q28817557-1EE37C07-00FC-4D9F-B1D3-323C55860FA5 Q36106321-6C1D4B74-9BC8-416C-9C6E-332B05A55A01 Q36140493-2788B34E-4E12-4477-B484-8A1BE6F39658 Q36550641-B3572683-EBB5-4FC6-84C1-C44A427D9282 Q36571294-6753DF2C-A4F7-493B-BA89-49145C916405 Q36666948-FCBEDD31-CA0C-47C4-8D59-4805EF483920 Q36838775-F02F8D09-AEEF-4D9D-91A5-D7D1ED82BE62 Q37317259-D1D17150-E726-4DB7-AA26-80294B9CD7FC Q37408958-57327958-CDBD-4F44-BFDA-92FDAA604756 Q37743246-9A831BAA-A043-460F-93C5-76FA8B572D06 Q38549159-1F32AA52-EAB5-49D2-B607-D5DCB55E1BA1 Q38783504-4CC349BD-E20B-46B0-A07D-45FBD0E89D6D Q38896426-A70B94F8-568A-40B0-B4A8-502A9587BDFF Q42317719-9858F537-4B44-408C-A15E-58F0E908DE7C Q42343331-310DFF91-8381-4637-9888-63C5B536324F Q43208282-9EDBE84A-6D83-484B-AE00-42D847BED95C Q43276399-95FE8FF1-8EA3-437F-938F-7864BA973F3C Q43459319-F56F78FB-84ED-4523-AEF0-D5CE10FF6987 Q47093459-F4DB4E8E-62DD-4365-9B64-6725E1BFFDBA Q47103829-D927F381-CB33-4728-BC4C-2972A87EBE2F Q47367521-819EA627-0A18-42B5-BCA6-3418F1F6E728 Q47445843-FB23BEB8-D38D-4BE7-B487-A1631CEDB04B Q48218051-D810A8BA-75C2-470E-A6D4-C317F58E9E7C Q49165909-4EAA42F0-AFC2-4B50-82A4-91BC09A2963A Q49396002-445FDC4D-211C-4194-838A-32A03BD4DED0 Q49686976-FA35D4D4-06C7-40AB-BEEC-4DEBC2BFC32B Q50045797-8B2F70E4-7865-48E1-9486-DFB7EFE90E25 Q50069373-7F173194-FFC3-4614-B028-7BC865D94498 Q52093269-BCF7A4F8-8A2C-4E64-BE03-2815645E5991 Q54157077-19462170-DA57-4F34-AAA0-1D317295F363 Q54976797-E6589E79-CD6D-40DA-8A30-F3C661703AA0 Q55461906-4210672F-8A4C-4AA6-919C-1A4BBB877D86

P2860

Loss of circadian clock gene expression is associated with tumor progression in breast cancer.

http://www.wikidata.org/entity/Q36185967

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Loss of circadian clock gene e ...... progression in breast cancer.

@ast

Loss of circadian clock gene e ...... progression in breast cancer.

@en

type

label

Loss of circadian clock gene e ...... progression in breast cancer.

@ast

Loss of circadian clock gene e ...... progression in breast cancer.

@en

prefLabel

Loss of circadian clock gene e ...... progression in breast cancer.

@ast

Loss of circadian clock gene e ...... progression in breast cancer.

@en

P1433

Q36185967-2A466688-786D-4D8A-A4EA-CCD15D72127A

P1476

Q36185967-E014E260-CEC5-4996-B7B6-24D01927F735

P2093

Q36185967-04C59021-4101-46EC-9761-A20628498E0D

Q36185967-622857E4-DA9C-49A6-BBAE-65EE50539FD6

Q36185967-92167CBF-462A-4AB7-B0A0-91B8C4538F62

Q36185967-97603446-9D99-40EF-B8C9-02CD6BD0589C

Q36185967-9E1F89D8-39E3-44E5-8008-F6671ED2E9D2

Q36185967-DB06620A-9589-4077-AA69-810EABF23630

P2860

Q36185967-46C5F6E8-8664-4528-9659-909B8133F616

Q36185967-46FEC5B0-3029-4656-AD22-54895A53B9EA

Q36185967-4CA9F77A-9D91-4A30-9FC0-01C929BE3483

Q36185967-4ED9A4EC-5A70-4FF9-8482-34AF4507D0EB

Q36185967-4F15D950-03F5-4856-BAF6-CE704EA135F8

Q36185967-4F2F4E29-F1D9-44A5-8427-E2111482670B

Q36185967-4F443836-0710-4741-84AA-D47141E1684B

Q36185967-4FEC64AA-F188-4EE1-B292-A3056193C9FE

Q36185967-567494D8-459B-4FE4-9102-76B1C02BB85E

Q36185967-596B4E66-EAB7-4749-8A86-B23A66FBAA03

P304

Q36185967-B3FC240A-FB9A-413B-B8CA-BA8C59ADB123

P31

Q36185967-F57D8048-59BC-442C-B8E5-3548506AB6C8

P356

Q36185967-CC9D23FB-DE28-4A75-9DF5-412853EFE697

P433

Q36185967-FD1F4AFC-9B3B-4E89-AC64-9960142C5129

P478

Q36185967-03FA7DA3-9835-4322-BEA4-1397988A4E3D

P50

Q36185967-51D32E81-FCA2-4228-A768-6EC1087C1070

Q36185967-A00E08D8-16B1-4E27-B2DE-DE2A1849E488

Q36185967-DD4412A7-3F89-4043-A0FA-08C6BC1DD531

Q36185967-F44023A5-70E2-4831-B33F-0F45EEACC2C8

P577

Q36185967-C8EB3633-61E7-4C62-BA55-3AA125CA0902

P5875

Q36185967-1540C8F7-43D6-438A-9004-B3879CDC5639

P698

Q36185967-AF0470B0-E4D2-4E3F-A298-9C5F08F27B6D

P921

Q36185967-D43AFD2C-72CA-4ECA-847B-1827CA8176E7

P932

Q36185967-DCBB7CBA-8694-4E1D-ABD8-0B29EF53AEEC

P356

15384101.2014.954454

P1433

P1476

Loss of circadian clock gene e ...... r progression in breast cancer

@en

P2093

Cristina Cadenas

http://www.w3.org/2001/XMLSchema#string

Henrik Oster

http://www.w3.org/2001/XMLSchema#string

Karolina Edlund

http://www.w3.org/2001/XMLSchema#string

Leonie van de Sandt

http://www.w3.org/2001/XMLSchema#string

Marcus Schmidt

http://www.w3.org/2001/XMLSchema#string

Miriam Lohr

http://www.w3.org/2001/XMLSchema#string

P2860

Mammalian TIMELESS is involved in period determination and DNA damage-dependent phase advancing of the circadian clock

Coordination of circadian timing in mammals

System-level identification of transcriptional circuits underlying mammalian circadian clocks.

The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo

Molecular components of the mammalian circadian clock

Antiphase circadian expression between BMAL1 and period homologue mRNA in the suprachiasmatic nucleus and peripheral tissues of rats

mCRY1 and mCRY2 are essential components of the negative limb of the circadian clock feedback loop

Central and peripheral circadian clocks in mammals

The mammalian circadian timing system: organization and coordination of central and peripheral clocks

Potential cancer-related role of circadian gene TIMELESS suggested by expression profiling and in vitro analyses

P304

3282-3291

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/15384101.2014.954454

http://www.w3.org/2001/XMLSchema#string

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Jörg Rahnenführer

Rosemarie Marchan

Jan G Hengstler

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

269282804

http://www.w3.org/2001/XMLSchema#string

P698

25485508

http://www.w3.org/2001/XMLSchema#string

P921

circadian rhythm

P932

4613905

http://www.w3.org/2001/XMLSchema#string